The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for In2Bones sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
In2Bones is a medical equipment company that designs, manufactures, and supplies implant devices for orthopaedic surgery. The company offers ankle fusion systems, midfoot plates, MTP plates, distal radius plates, compression and neutralization screws, and compression staples. Its products are used in hand, wrist, foot, and ankle surgery. In2Bones is headquartered in Ecully, Rhone Alpes, France.
The key metrics of In2Bones related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As In2Bones is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as In2Bones.
For a detailed understanding of the performance of In2Bones, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.